new glp 1 drug retatrutide drmcgowan was just featured in USA Today as an expert voice on the biggest weight loss story of the year. π° Eli Lilly's drug just posted the most significant Demand for Unapproved Weight-Loss Drug
Description
The current therapeutic paradigm for diabetes management entails a comprehensive, multi-modal strategy encompassing both lifestyle and pharmacological interventions
Key GLP1 ,
Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, et al
Our latest article, written in partnership with AULV Health, explores why metabolic dysfunction may become one of the biggest opportunities in #cannabinoid medicine
Incorporating considerations of resources use into grading recommendations
More than half of the tirzepatide group lost at least 20% of body weight, compared to about a quarter of the semaglutide group
